-
-
NCT00653952
-
Primary Citation Not available
-
You are not logged in.
Please login to continue selecting trials.
Trial Information
Generic NameDoxorubicin hydrochlorideProduct NameDOXIL®Therapeutic AreaCancers and Other NeoplasmsEnrollment220% Female100%% White97.2%
Product ClassOncology - AntibioticSponsor Protocol Number30-57Data PartnerJohnson & JohnsonCondition StudiedNeoplasms, OvarianMean/Median Age (Years)N/A
Supporting Documentation
- Collected Datasets Available
- Data Definition Specification Available
- Protocol with Amendments Available
- Statistical Analysis Plan Available
- Clinical Study Report Available
Additional Information
Protocol with Amendments included in Appendix 1.1 of the CSR
Statistical Analysis Plan included in Appendix 2.2 of the CSR